{"pmid":32330122,"title":"Panic prescribing has become omnipresent during the COVID-19 pandemic.","text":["Panic prescribing has become omnipresent during the COVID-19 pandemic.","Lessons from the Ebola outbreak shows that it is possible to develop rapid and effective clinical research responses without relying on anecdote.","J Clin Invest","Caplan, Arthur L","Upshur, Ross","32330122"],"abstract":["Lessons from the Ebola outbreak shows that it is possible to develop rapid and effective clinical research responses without relying on anecdote."],"journal":"J Clin Invest","authors":["Caplan, Arthur L","Upshur, Ross"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330122","week":"202017|Apr 20 - Apr 26","doi":"10.1172/JCI139562","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664996914856198145,"score":8.518259,"similar":[{"pmid":32278175,"pmcid":"PMC7128376","title":"COVID-19: A promising cure for the global panic.","text":["COVID-19: A promising cure for the global panic.","The novel Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, which is the causative agent of a potentially fatal disease that is of great global public health concern. The outbreak of COVID-19 is wreaking havoc worldwide due to inadequate risk assessment regarding the urgency of the situation. The COVID-19 pandemic has entered a dangerous new phase. When compared with SARS and MERS, COVID-19 has spread more rapidly, due to increased globalization and adaptation of the virus in every environment. Slowing the spread of the COVID-19 cases will significantly reduce the strain on the healthcare system of the country by limiting the number of people who are severely sick by COVID-19 and need hospital care. Hence, the recent outburst of COVID-19 highlights an urgent need for therapeutics targeting SARS-CoV-2. Here, we have discussed the structure of virus; varying symptoms among COVID-19, SARS, MERS and common flu; the probable mechanism behind the infection and its immune response. Further, the current treatment options, drugs available, ongoing trials and recent diagnostics for COVID-19 have been discussed. We suggest traditional Indian medicinal plants as possible novel therapeutic approaches, exclusively targeting SARS-CoV-2 and its pathways.","Sci Total Environ","Vellingiri, Balachandar","Jayaramayya, Kaavya","Iyer, Mahalaxmi","Narayanasamy, Arul","Govindasamy, Vivekanandhan","Giridharan, Bupesh","Ganesan, Singaravelu","Venugopal, Anila","Venkatesan, Dhivya","Ganesan, Harsha","Rajagopalan, Kamarajan","Rahman, Pattanathu K S M","Cho, Ssang-Goo","Kumar, Nachimuthu Senthil","Subramaniam, Mohana Devi","32278175"],"abstract":["The novel Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, which is the causative agent of a potentially fatal disease that is of great global public health concern. The outbreak of COVID-19 is wreaking havoc worldwide due to inadequate risk assessment regarding the urgency of the situation. The COVID-19 pandemic has entered a dangerous new phase. When compared with SARS and MERS, COVID-19 has spread more rapidly, due to increased globalization and adaptation of the virus in every environment. Slowing the spread of the COVID-19 cases will significantly reduce the strain on the healthcare system of the country by limiting the number of people who are severely sick by COVID-19 and need hospital care. Hence, the recent outburst of COVID-19 highlights an urgent need for therapeutics targeting SARS-CoV-2. Here, we have discussed the structure of virus; varying symptoms among COVID-19, SARS, MERS and common flu; the probable mechanism behind the infection and its immune response. Further, the current treatment options, drugs available, ongoing trials and recent diagnostics for COVID-19 have been discussed. We suggest traditional Indian medicinal plants as possible novel therapeutic approaches, exclusively targeting SARS-CoV-2 and its pathways."],"journal":"Sci Total Environ","authors":["Vellingiri, Balachandar","Jayaramayya, Kaavya","Iyer, Mahalaxmi","Narayanasamy, Arul","Govindasamy, Vivekanandhan","Giridharan, Bupesh","Ganesan, Singaravelu","Venugopal, Anila","Venkatesan, Dhivya","Ganesan, Harsha","Rajagopalan, Kamarajan","Rahman, Pattanathu K S M","Cho, Ssang-Goo","Kumar, Nachimuthu Senthil","Subramaniam, Mohana Devi"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32278175","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.scitotenv.2020.138277","keywords":["coronavirus disease 2019 (covid-19)","indian traditional medicine","mechanism of action","sars-cov-2","therapeutic approach"],"source":"PubMed","topics":["Treatment"],"weight":1,"locations":["Indian"],"countries":["India"],"countries_codes":["IND|India"],"_version_":1664636943898509312,"score":73.63626},{"pmid":32328511,"pmcid":"PMC7177085","title":"Dermatoethics: Self-Prescribing Plaquenil during the COVID-19 Pandemic.","text":["Dermatoethics: Self-Prescribing Plaquenil during the COVID-19 Pandemic.","Int J Womens Dermatol","Stoj, Victoria J","Grant-Kels, Jane M","32328511"],"journal":"Int J Womens Dermatol","authors":["Stoj, Victoria J","Grant-Kels, Jane M"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32328511","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.ijwd.2020.04.006","keywords":["covid-19","dermatoethics","hydroxychloroquine","justice","non-maleficence"],"source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Hydroxychloroquine"],"_version_":1664996914771263490,"score":72.690636},{"pmid":32307545,"title":"Social media panic and COVID-19 in India.","text":["Social media panic and COVID-19 in India.","Social media has played a crucial role in spreading awareness and knowledge about public health; however, it has also been misused for spreading fake news, hatred and creating racism during epidemics and civil unrest. We discuss how social media and societal response to COVID-19 negatively affected its control measures in India and what should be possible corrective measures.","J Travel Med","Kadam, Abhay B","Atre, Sachin R","32307545"],"abstract":["Social media has played a crucial role in spreading awareness and knowledge about public health; however, it has also been misused for spreading fake news, hatred and creating racism during epidemics and civil unrest. We discuss how social media and societal response to COVID-19 negatively affected its control measures in India and what should be possible corrective measures."],"journal":"J Travel Med","authors":["Kadam, Abhay B","Atre, Sachin R"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32307545","week":"202017|Apr 20 - Apr 26","doi":"10.1093/jtm/taaa057","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["India","India"],"countries":["India"],"countries_codes":["IND|India"],"_version_":1664632501480456192,"score":64.62071},{"pmid":32335585,"title":"The Coronavirus Pandemic: What Does the Evidence Show?","text":["The Coronavirus Pandemic: What Does the Evidence Show?","Coronavirus disease 2019 (COVID-19) is a newly emerged disease that has become a global public health concern as it rapidly spread around the world. The etiologic agent responsible for this disease has been named as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses as it shows similar genomic features to that of SARS-CoV which caused a pandemic in 2002. This disease first appeared in Hubei province of China and it follows human-to-human transmission but the path this virus took to set up human infection remains a mystery. By 17 April 2020, globally there have been 2,074,529 confirmed cases with 139,378 deaths because of COVID-19. SARS-CoV-2 shows several similarities with SARS?CoV, and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) with its clinical presentations. This can vary from asymptomatic infection to severe disease and mortality. Real-time reverse-transcription polymerase chain reaction (rRT-PCR) screening is considered as the standard laboratory test for the diagnosis of COVID-19. There is no proven antiviral agent against SARS-CoV-2 so the treatment for COVID-19 is symptomatic, aiming for the management of the symptoms and prevention of the complications. The outbreak of COVID-19 has led to the implementation of extraordinary public health measures throughout the world. Numerous antiviral compounds used to treat other infections are being clinically researched to find possible treatment. Similarly, the traditional public health outbreak response strategy of isolation, quarantine, social distancing and community containment has been implemented in multiple countries and has played an important role in the prevention of new outbreaks. This review aims to enhance our understanding of COVID 19. Keywords: Coronavirus disease 2019; COVID-19; SARS-CoV-2; novel coronavirus 2019; severe acute respiratory syndrome-2.","J Nepal Health Res Counc","Paudel, Shishir","Dangal, Ganesh","Chalise, Anisha","Bhandari, Tulsi Ram","Dangal, Ojash","32335585"],"abstract":["Coronavirus disease 2019 (COVID-19) is a newly emerged disease that has become a global public health concern as it rapidly spread around the world. The etiologic agent responsible for this disease has been named as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses as it shows similar genomic features to that of SARS-CoV which caused a pandemic in 2002. This disease first appeared in Hubei province of China and it follows human-to-human transmission but the path this virus took to set up human infection remains a mystery. By 17 April 2020, globally there have been 2,074,529 confirmed cases with 139,378 deaths because of COVID-19. SARS-CoV-2 shows several similarities with SARS?CoV, and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) with its clinical presentations. This can vary from asymptomatic infection to severe disease and mortality. Real-time reverse-transcription polymerase chain reaction (rRT-PCR) screening is considered as the standard laboratory test for the diagnosis of COVID-19. There is no proven antiviral agent against SARS-CoV-2 so the treatment for COVID-19 is symptomatic, aiming for the management of the symptoms and prevention of the complications. The outbreak of COVID-19 has led to the implementation of extraordinary public health measures throughout the world. Numerous antiviral compounds used to treat other infections are being clinically researched to find possible treatment. Similarly, the traditional public health outbreak response strategy of isolation, quarantine, social distancing and community containment has been implemented in multiple countries and has played an important role in the prevention of new outbreaks. This review aims to enhance our understanding of COVID 19. Keywords: Coronavirus disease 2019; COVID-19; SARS-CoV-2; novel coronavirus 2019; severe acute respiratory syndrome-2."],"journal":"J Nepal Health Res Counc","authors":["Paudel, Shishir","Dangal, Ganesh","Chalise, Anisha","Bhandari, Tulsi Ram","Dangal, Ojash"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335585","week":"202018|Apr 27 - May 03","doi":"10.33314/jnhrc.v18i1.2596","source":"PubMed","topics":["Diagnosis","Mechanism","Treatment","Prevention"],"weight":1,"_version_":1665172301891502080,"score":58.75278},{"pmid":32267566,"title":"Therapeutic Potential for Tetracyclines in the Treatment of COVID-19.","text":["Therapeutic Potential for Tetracyclines in the Treatment of COVID-19.","Currently there is a race against time to identify prophylactic and therapeutic treatments against COVID-19. Until these treatments are developed, tested and mass produced, it might be prudent to look into existing therapies that could be effective against this virus. Based on the available evidence we believe that tetracyclines may be effective agents in the treatment of COVID-19. Tetracyclines (e.g. tetracycline, doxycycline, and minocycline) are highly lipophilic antibiotics that are known to chelate zinc compounds on matrix metalloproteinases (MMPs)(1) . Coronaviruses are also known to heavily rely on host MMPs for survival, cell infiltration, cell to cell adhesion, and replication, many of which have zinc as part of their MMP complex(2,3) . It is possible that the zinc chelating properties of tetracyclines may also aid in inhibiting COVID-19 infection in humans limiting their ability to replicate within the host.","Pharmacotherapy","Sodhi, Mohit","Etminan, Mahyar","32267566"],"abstract":["Currently there is a race against time to identify prophylactic and therapeutic treatments against COVID-19. Until these treatments are developed, tested and mass produced, it might be prudent to look into existing therapies that could be effective against this virus. Based on the available evidence we believe that tetracyclines may be effective agents in the treatment of COVID-19. Tetracyclines (e.g. tetracycline, doxycycline, and minocycline) are highly lipophilic antibiotics that are known to chelate zinc compounds on matrix metalloproteinases (MMPs)(1) . Coronaviruses are also known to heavily rely on host MMPs for survival, cell infiltration, cell to cell adhesion, and replication, many of which have zinc as part of their MMP complex(2,3) . It is possible that the zinc chelating properties of tetracyclines may also aid in inhibiting COVID-19 infection in humans limiting their ability to replicate within the host."],"journal":"Pharmacotherapy","authors":["Sodhi, Mohit","Etminan, Mahyar"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32267566","week":"202015|Apr 06 - Apr 12","doi":"10.1002/phar.2395","source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Tetracyclines","Minocycline","Tetracycline","Doxycycline"],"_version_":1664637636066672640,"score":57.72865}]}